BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36057740)

  • 1. PD-L1 and PD-1 expression in pediatric central nervous system germ cell tumors.
    Woods JK; Lidov HG; Ligon KL; Santagata S; Chi SN; Yeo KK; Alexandrescu S
    Mod Pathol; 2022 Dec; 35(12):1770-1774. PubMed ID: 36057740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors.
    Satomi K; Takami H; Fukushima S; Yamashita S; Matsushita Y; Nakazato Y; Suzuki T; Tanaka S; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Kobayashi K; Nagane M; Iuchi T; Yoshimoto K; Tamura K; Maehara T; Sakai K; Sugiyama K; Yokogami K; Takeshima H; Nonaka M; Asai A; Ushijima T; Matsutani M; Nishikawa R; Ichimura K
    Neuro Oncol; 2022 May; 24(5):834-846. PubMed ID: 34698864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI features of pediatric intracranial germ cell tumor subtypes.
    Wu CC; Guo WY; Chang FC; Luo CB; Lee HJ; Chen YW; Lee YY; Wong TT
    J Neurooncol; 2017 Aug; 134(1):221-230. PubMed ID: 28551848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central Nervous System Germinomas Express Programmed Death Ligand 1.
    Wildeman ME; Shepard MJ; Oldfield EH; Lopes MBS
    J Neuropathol Exp Neurol; 2018 Apr; 77(4):312-316. PubMed ID: 29415126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain and Spinal Tumors Originating from the Germ Line Cells.
    Wong TT; Tsai ML; Chang H; Hsieh KL; Ho DM; Lin SC; Yen HJ; Chen YW; Lee HL; Yang TF
    Adv Exp Med Biol; 2023; 1405():421-455. PubMed ID: 37452948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-institutional analysis of central nervous system germ cell tumors in patients with Down syndrome.
    Harris MK; Graham RT; Cappellano AM; Margol AS; Michaiel G; Crawford JR; Ioakeim-Ioannidou M; Stanek JR; Liu KX; MacDonald SM; Abdelbaki MS
    Pediatr Blood Cancer; 2022 Oct; 69(10):e29830. PubMed ID: 35686831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and immunohistochemical features of primary central nervous system germ cell tumors: a 24-years experience.
    Gao Y; Jiang J; Liu Q
    Int J Clin Exp Pathol; 2014; 7(10):6965-72. PubMed ID: 25400782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric central nervous system germ cell tumors: a review.
    Echevarría ME; Fangusaro J; Goldman S
    Oncologist; 2008 Jun; 13(6):690-9. PubMed ID: 18586924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome and methylome analysis of CNS germ cell tumor finds its cell-of-origin in embryogenesis and reveals shared similarities with testicular counterparts.
    Takami H; Elzawahry A; Mamatjan Y; Fukushima S; Fukuoka K; Suzuki T; Yanagisawa T; Matsushita Y; Nakamura T; Satomi K; Tanaka S; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Kobayashi K; Nagane M; Iuchi T; Tamura K; Maehara T; Sugiyama K; Yoshimoto K; Sakai K; Nonaka M; Asai A; Yokogami K; Takeshima H; Narita Y; Shibui S; Nakazato Y; Hama N; Totoki Y; Kato M; Shibata T; Nishikawa R; Matsutani M; Ichimura K
    Neuro Oncol; 2022 Aug; 24(8):1246-1258. PubMed ID: 35137206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy.
    Ichimura K; Fukushima S; Totoki Y; Matsushita Y; Otsuka A; Tomiyama A; Niwa T; Takami H; Nakamura T; Suzuki T; Fukuoka K; Yanagisawa T; Mishima K; Nakazato Y; Hosoda F; Narita Y; Shibui S; Yoshida A; Mukasa A; Saito N; Kumabe T; Kanamori M; Tominaga T; Kobayashi K; Shimizu S; Nagane M; Iuchi T; Mizoguchi M; Yoshimoto K; Tamura K; Maehara T; Sugiyama K; Nakada M; Sakai K; Kanemura Y; Nonaka M; Asai A; Yokogami K; Takeshima H; Kawahara N; Takayama T; Yao M; Kato M; Nakamura H; Hama N; Sakai R; Ushijima T; Matsutani M; Shibata T; Nishikawa R;
    Acta Neuropathol; 2016 Jun; 131(6):889-901. PubMed ID: 26956871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T2*-based MR imaging (gradient echo or susceptibility-weighted imaging) in midline and off-midline intracranial germ cell tumors: a pilot study.
    Morana G; Alves CA; Tortora D; Finlay JL; Severino M; Nozza P; Ravegnani M; Pavanello M; Milanaccio C; Maghnie M; Rossi A; Garrè ML
    Neuroradiology; 2018 Jan; 60(1):89-99. PubMed ID: 29128947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of intracranial non-germinomatous germ cell tumors: a retrospective Asian multinational study on treatment strategies and prognostic factors.
    Hong KT; Han JW; Fuji H; Byun HK; Koh KN; Wong RX; Lee HL; Yoon HI; Lee JH; Phi JH; Kim SK; Kim DS; Lyu CJ; Choi JY; Kang HJ; Chen YW; Lee YY; Im HJ; Ra YS; Do Ahn S; Low SYY; Looi WS; Park HJ; Suh YG; Suh CO; Wang KC; Tan EEK; Wong TT; Kim JY
    J Neurooncol; 2022 Oct; 160(1):41-53. PubMed ID: 36045266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor immune microenvironment is associated with the growth of intracranial germinomas.
    Nishimoto M; Ohara K; Kamamoto D; Tamura R; Miwa T; Yoshida K; Sasaki H
    J Neurooncol; 2020 Jan; 146(1):139-146. PubMed ID: 31773448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors.
    Cierna Z; Mego M; Miskovska V; Machalekova K; Chovanec M; Svetlovska D; Hainova K; Rejlekova K; Macak D; Spanik S; Ondrus D; Kajo K; Mardiak J; Babal P
    Ann Oncol; 2016 Feb; 27(2):300-5. PubMed ID: 26598537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evolving Exploration of the Pathogenesis of CNS Germ Cell Tumors with Regard to Precision Medicine].
    Takami H; Takayanagi S; Tanaka S; Saito N
    No Shinkei Geka; 2022 Jan; 50(1):39-50. PubMed ID: 35169085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct patterns of copy number alterations may predict poor outcome in central nervous system germ cell tumors.
    Takami H; Satomi K; Fukuoka K; Nakamura T; Tanaka S; Mukasa A; Saito N; Suzuki T; Yanagisawa T; Sugiyama K; Kanamori M; Kumabe T; Tominaga T; Tamura K; Maehara T; Nonaka M; Asai A; Yokogami K; Takeshima H; Iuchi T; Kobayashi K; Yoshimoto K; Sakai K; Nakazato Y; Matsutani M; Nagane M; Nishikawa R; Ichimura K
    Sci Rep; 2023 Sep; 13(1):15760. PubMed ID: 37735187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The value of CXorf67 and H3K27me3 for diagnosing germ cell tumors in central nervous system].
    Liu YF; Hu XM; Du ZG; Wang Y; Tang F; Xiong J
    Zhonghua Bing Li Xue Za Zhi; 2022 May; 51(5):407-412. PubMed ID: 35511635
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary Central Nervous System Germ Cell Tumors: A Review and Update.
    Fetcko K; Dey M
    Med Res Arch; 2018 Mar; 6(3):. PubMed ID: 30271875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical characteristics and treatment outcome of 57 children and adolescents with primary central nervous system germ cell tumors.
    Sun XF; Zhang F; Zhen ZJ; Yang QY; Xia YF; Wu SX; Zhu J; Lu SY; Wang J; Sun FF; Cai RQ; Chen Y; Li PF
    Chin J Cancer; 2014 Aug; 33(8):395-401. PubMed ID: 25011460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence patterns of central nervous system germ cell tumors: a SEER Study.
    Goodwin TL; Sainani K; Fisher PG
    J Pediatr Hematol Oncol; 2009 Aug; 31(8):541-4. PubMed ID: 19636276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.